PATENT CLAIM ANALYSIS

Application Number: 15885462
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-12
Patent Classification: ["514", "253040"]

Abstract:
The present invention relates to stable liquid formulations of ketoprofen, amitriptyline, and oxymetazoline.

Claim (Index 14):
The pharmaceutical formulation of  claim 1 , wherein the ketoprofen, amitriptyline, oxymetazoline are stable for at least twelve months when stored at a temperature of between 2\u00b0 C. and 30\u00b0 C.

Metadata:
- Claim Count in Document: 83.0
- Percentile: 86.0
- Lexical Diversity: 1.06667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13047386', '10138192', '12384781', '14721151', '14061039']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7740117793849728
- 35 USC 102 Novelty (BERT): 0.5162725401572197
- Combined Prediction Score: 0.7482378554621976
- Mean Citation Score: 282.707414
- Max Citation Score: 305.0422700000001
- Similarity Product: 227.70278640916592

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test